{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:15:35Z","timestamp":1791216935155,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":3137,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1038\/sj.jid.5700689","type":"journal-article","created":{"date-parts":[[2007,1,11]],"date-time":"2007-01-11T16:02:58Z","timestamp":1168531378000},"page":"1234-1243","source":"Crossref","is-referenced-by-count":53,"title":["CDKN2A Germline Mutations in Individuals with Cutaneous Malignant Melanoma"],"prefix":"10.1016","volume":"127","author":[{"given":"Irene","family":"Orlow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin B.","family":"Begg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Cotignola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pampa","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Hummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Clas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urvi","family":"Mujumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Canchola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce K.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loraine D.","family":"Marrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Millikan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Anton-Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Rebbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Kanetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homer","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Busam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"From","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Berwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"for the GEM Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.jid.5700689_bb0010","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/jnci\/91.5.446","article-title":"CDKN2A variants in a population-based sample of Queensland families with melanoma","volume":"91","author":"Aitken","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/sj.jid.5700689_bb0015","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ijc.21265","article-title":"The melanoma-associated 24 base pair duplication in p16INK4a is functionally impaired","volume":"117","author":"Becker","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1038\/sj.jid.5700689_bb0020","first-page":"3282","article-title":"Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding","volume":"7","author":"Becker","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1038\/sj.jid.5700689_bb0025","first-page":"99","article-title":"A note on the estimation of relative risks of rare genetic susceptibility markers","volume":"6","author":"Begg","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1038\/sj.jid.5700689_bb0030","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/ije\/dyl044","article-title":"A design for cancer case\u2013control studies using only incident cases: experience with the GEM study of melanoma","volume":"35","author":"Begg","year":"2006","journal-title":"Int J Epidemiol"},{"key":"10.1038\/sj.jid.5700689_bb0035","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/jnci\/dji312","article-title":"Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample","volume":"97","author":"Begg","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/sj.jid.5700689_bb0040","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1055-9965.EPI-06-0270","article-title":"The prevalence of CDKN2A germline mutations and relative risk for cutaneous malignant melanoma: an international population-based study","volume":"15","author":"Berwick","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1038\/sj.jid.5700689_bb0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00008469-200402000-00010","article-title":"Estimating the relative risk of developing melanoma in INK4A carriers","volume":"13","author":"Berwick","year":"2004","journal-title":"Eur J Cancer Prev"},{"key":"10.1038\/sj.jid.5700689_bb0050","doi-asserted-by":"crossref","first-page":"R199","DOI":"10.1186\/bcr771","article-title":"Study design: evaluating gene\u2013environment interactions in the etiology of breast cancer","volume":"6","author":"Bernstein","year":"2004","journal-title":"Breast Cancer Res"},{"key":"10.1038\/sj.jid.5700689_bb0055","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/jnci\/94.12.894","article-title":"Geographical variation in the penetrance of CDKN2A mutations for melanoma","volume":"94","author":"Bishop","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/sj.jid.5700689_bb0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archderm.135.3.261","article-title":"Genetic and environmental influences in the development of multiple primary melanoma","volume":"135","author":"Burden","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1038\/sj.jid.5700689_bb0065","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/jmg.2005.031476","article-title":"A common variant of CDKN2A (p16) predisposes to breast cancer","volume":"42","author":"Debniak","year":"2005","journal-title":"J Med Genet"},{"key":"10.1038\/sj.jid.5700689_bb0070","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1158\/0008-5472.835.65.3","article-title":"CDKN2A common variants and their association with melanoma risk: a population-based study","volume":"65","author":"Debniak","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/sj.jid.5700689_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.humpath.2003.08.017","article-title":"Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients","volume":"35","author":"Ghiorzo","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1038\/sj.jid.5700689_bb0080","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/MCB.16.3.859","article-title":"Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence","volume":"16","author":"Hara","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1038\/sj.jid.5700689_bb0085","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/hmg\/6.12.2061","article-title":"Germline mutations of the CDKN2 gene in UK melanoma families","volume":"6","author":"Harland","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1038\/sj.jid.5700689_bb0090","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/gcc.20177","article-title":"Intronic sequence variants of the CDKN2A gene in melanoma pedigrees","volume":"43","author":"Harland","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/sj.jid.5700689_bb0095","first-page":"6864","article-title":"CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas","volume":"60","author":"Hashemi","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/sj.jid.5700689_bb0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","article-title":"Germline p16 mutations in familial melanoma","volume":"8","author":"Hussussian","year":"1994","journal-title":"Nat Genet"},{"key":"10.1038\/sj.jid.5700689_bb0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng0994-22","article-title":"Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus","volume":"8","author":"Kamb","year":"1994","journal-title":"Nat Genet"},{"key":"10.1038\/sj.jid.5700689_bb0110","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0092-8674(00)80452-3","article-title":"Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF","volume":"91","author":"Kamijo","year":"1997","journal-title":"Cell"},{"key":"10.1038\/sj.jid.5700689_bb0115","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/375506a0","article-title":"Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition","volume":"375","author":"Koh","year":"1995","journal-title":"Nature"},{"key":"10.1038\/sj.jid.5700689_bb0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/jmg.2005.033498","article-title":"Comprehensive analysis of cdkn2a (p16ink4a\/p14arf) and cdkn2b genes in 53 melanoma index cases considered to be at heightened risk of melanoma","volume":"43","author":"Laud","year":"2005","journal-title":"J Med Genet"},{"key":"10.1038\/sj.jid.5700689_bb0125","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/5082","article-title":"Mutation of the CDKN2A 5\u2032UTR creates an aberrant initiation codon and predisposes to melanoma","volume":"21","author":"Liu","year":"1999","journal-title":"Nat Genet"},{"key":"10.1038\/sj.jid.5700689_bb0130","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1038\/sj.onc.1206736","article-title":"Germline splicing mutations of CDKN2A predispose to melanoma","volume":"22","author":"Loo","year":"2003","journal-title":"Oncogene"},{"key":"10.1038\/sj.jid.5700689_bb0135","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1523-1747.1998.00267.x","article-title":"CDKN2A germline mutations in UK. Patients with familial melanoma and multiple primary melanomas","volume":"111","author":"MacKie","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1038\/sj.jid.5700689_bb0140","first-page":"2995","article-title":"A novel p16INK4A transcript","volume":"55","author":"Mao","year":"1995","journal-title":"Cancer Res"},{"key":"10.1038\/sj.jid.5700689_bb0145","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/gcc.20202","article-title":"A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation","volume":"44","author":"Molven","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/sj.jid.5700689_bb0150","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM199803263381305","article-title":"CDKN2A mutations in multiple primary melanomas","volume":"338","author":"Monzon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.jid.5700689_bb0155","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1101\/gr.176601","article-title":"Predicting deleterious amino acid substitutions","volume":"11","author":"Ng","year":"2001","journal-title":"Genome Res"},{"key":"10.1038\/sj.jid.5700689_bb0160","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1101\/gr.212802","article-title":"Accounting for human polymorphisms predicted to affect protein function","volume":"12","author":"Ng","year":"2002","journal-title":"Genome Res"},{"key":"10.1038\/sj.jid.5700689_bb0165","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/368753a0","article-title":"Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers","volume":"368","author":"Nobori","year":"1994","journal-title":"Nature"},{"key":"10.1038\/sj.jid.5700689_bb0170","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1525-1578(10)60667-8","article-title":"Validation of denaturing high performance liquid chromatography as a rapid detection method for the identification of human INK4A gene mutations","volume":"3","author":"Orlow","year":"2001","journal-title":"J Mol Diagn"},{"key":"10.1038\/sj.jid.5700689_bb0175","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1128\/MCB.16.7.3844","article-title":"Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma","volume":"16","author":"Parry","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1038\/sj.jid.5700689_bb0180","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.0022-202X.2004.22532.x","article-title":"CDKN2A and MC1R mutations in patients with sporadic multiple primary melanoma","volume":"122","author":"Peris","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1038\/sj.jid.5700689_bb0185","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/S0002-9440(10)65071-7","article-title":"INK4a\/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene","volume":"156","author":"Pinyol","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1038\/sj.jid.5700689_bb0190","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0092-8674(00)81400-2","article-title":"The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53","volume":"92","author":"Pomerantz","year":"1998","journal-title":"Cell"},{"key":"10.1038\/sj.jid.5700689_bb0195","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0092-8674(95)90214-7","article-title":"Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest","volume":"83","author":"Quelle","year":"1995","journal-title":"Cell"},{"key":"10.1038\/sj.jid.5700689_bb0200","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1093\/nar\/gkf493","article-title":"Human non-synonymous SNPs: server and survey","volume":"30","author":"Ramensky","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/sj.jid.5700689_bb0205","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ng0595-114","article-title":"Mutations associated with familial melanoma impair p16INK4 function","volume":"10","author":"Ranade","year":"1995","journal-title":"Nat Genet"},{"key":"10.1038\/sj.jid.5700689_bb0210","first-page":"1173","article-title":"p16 proteins from melanoma-prone families are deficient in binding to Cdk4","volume":"11","author":"Reymond","year":"1995","journal-title":"Oncogene"},{"key":"10.1038\/sj.jid.5700689_bb0215","first-page":"189","article-title":"Pyrosequencing for SNP genotyping","volume":"212","author":"Ronaghi","year":"2003","journal-title":"Methods Mol Biol"},{"key":"10.1038\/sj.jid.5700689_bb0220","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1038\/sj.onc.1202918","article-title":"Functional evaluation of tumour-specific variants of p16INK4a\/CDKN2A: correlation with protein structure information","volume":"18","author":"Ruas","year":"1999","journal-title":"Oncogene"},{"key":"10.1038\/sj.jid.5700689_bb0225","first-page":"F115","article-title":"The p16INK4a\/CDKN2A tumor suppressor and its relatives","volume":"1378","author":"Ruas","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/sj.jid.5700689_bb0230","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature"},{"key":"10.1038\/sj.jid.5700689_bb0235","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/hmg\/7.2.209","article-title":"Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group","volume":"7","author":"Soufir","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1038\/sj.jid.5700689_bb0240","first-page":"2988","article-title":"Complex structure and regulation of the P16 (MTS1) locus","volume":"55","author":"Stone","year":"1995","journal-title":"Cancer Res"},{"key":"10.1038\/sj.jid.5700689_bb0245","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0002-9440(10)64174-0","article-title":"Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase","volume":"161","author":"Straume","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1038\/sj.jid.5700689_bb0250","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0168-9525(00)01988-0","article-title":"Towards a structural basis of human non-synonymous single nucleotide polymorphisms","volume":"16","author":"Sunyaev","year":"2000","journal-title":"Trends Genet"},{"key":"10.1038\/sj.jid.5700689_bb0255","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/hmg\/10.6.591","article-title":"Prediction of deleterious human alleles","volume":"10","author":"Sunyaev","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1038\/sj.jid.5700689_bb0260","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1093\/nar\/gkg574","article-title":"PARSESNP: a tool for the analysis of nucleotide polymorphisms","volume":"31","author":"Taylor","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/sj.jid.5700689_bb0265","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/archderm.136.9.1118","article-title":"Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma","volume":"136","author":"Tsao","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1038\/sj.jid.5700689_bb0270","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<305::AID-IJC24>3.0.CO;2-Z","article-title":"Functional reassessment of P16 variants using a transfection-based assay","volume":"82","author":"Walker","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1038\/sj.jid.5700689_bb0275","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/4.10.1845","article-title":"Mutations of the CDKN2\/p16INK4 gene in Australian melanoma kindreds","volume":"4","author":"Walker","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1038\/sj.jid.5700689_bb0280","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/MCB.20.7.2517-2528.2000","article-title":"Cooperative signals governing ARF\u2013mdm2 interaction and nucleolar localization of the complex","volume":"20","author":"Weber","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1038\/sj.jid.5700689_bb0285","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/jnci\/91.18.1569","article-title":"Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors","volume":"91","author":"Yarbrough","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/sj.jid.5700689_bb0290","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1349-7006.2005.00003.x","article-title":"Primary malignant lymphoma of the brain: frequent abnormalities and inactivation of p14 tumor suppressor gene","volume":"96","author":"Zhang","year":"2005","journal-title":"Cancer Sci"},{"key":"10.1038\/sj.jid.5700689_bb0295","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0196-97","article-title":"Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma","volume":"12","author":"Zuo","year":"1996","journal-title":"Nat Genet"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15333881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15333881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T10:06:45Z","timestamp":1683713205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15333881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0022202X15333881"],"URL":"https:\/\/doi.org\/10.1038\/sj.jid.5700689","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}